Skip to main content
Clinical Trials/NCT02921282
NCT02921282
Completed
Not Applicable

Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms

Centre for Addiction and Mental Health1 site in 1 country26 target enrollmentAugust 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cigarette Smoking Behavior
Sponsor
Centre for Addiction and Mental Health
Enrollment
26
Locations
1
Primary Endpoint
Number of puffs on a cigarette
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

In this study, potential associations between several genetic polymorphisms and nicotine dependence will be examined. The relative reinforcing efficacy of cigarettes using the forced-choice procedure will be assessed. In addition, reactivity to smoking cues using a reliable procedure will be conducted.

Detailed Description

It is known that cannabinoid and dopamine receptors can be important modulators of response to nicotine and its associated cues. In this study participants will be genotyped to determine whether there is a relationship between CB1 or D3 genes and the reinforcing properties of nicotine or the subjective effects of nicotine-associated cues. In one session, participants will chose between two different cigarettes, each with different properties. In another session, physiological responses and craving will be measured when presented with cues that remind participants of nicotine. At some point during the study, blood will be collected for genotyping and this will processed to study whether CB1 or D3 genotype influences these responses to nicotine or cues.

Registry
clinicaltrials.gov
Start Date
August 2016
End Date
November 29, 2019
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Bernard Le Foll

Scientist

Centre for Addiction and Mental Health

Eligibility Criteria

Inclusion Criteria

  • 19-64 year old males and females
  • smoking at least 10 cigarettes per day for at least 1 year
  • positive urinary cotinine
  • medically and psychologically healthy as determined by screening criteria

Exclusion Criteria

  • definite plan to reduce or quit tobacco use during the course of the study
  • treatment for tobacco dependence in the past 3 months
  • use of nicotine replacement products, bupropion, or varenicline in the past 3 months
  • consumption of more than 15 alcoholic drinks per week during the past month
  • use of any illicit drug more than twice per week during the past month
  • current use of any medication that would interfere with the protocol in the opinion of PI
  • under the influence of a drug or alcohol at any session
  • pregnant, nursing, or become pregnant during the study

Outcomes

Primary Outcomes

Number of puffs on a cigarette

Time Frame: 3 years

Puffs taken from either a nicotinized or a denicotinized cigarette

Secondary Outcomes

  • Craving in response to nicotine cues(3 years)
  • Physiological measures in response to cues(3 years)

Study Sites (1)

Loading locations...

Similar Trials